Literature DB >> 11023483

Effects of antibiotic class on the macrophage inflammatory response to Streptococcus pneumoniae.

K L Orman1, B K English.   

Abstract

Antibiotic choice can alter host inflammation during invasive bacterial infections. Previous studies of gram-negative organisms concluded that antibiotic-mediated release of bacterial cell wall components amplifies inflammation. Less has been reported about antibiotic effect on gram-positive organisms. This study explored the hypothesis that Streptococcus pneumoniae would induce greater macrophage inflammatory mediator production when killed with cell wall active antibiotics rather than protein synthesis inhibitors. Stimulation of RAW 264.7 murine macrophages with pneumococci and oxacillin led to significantly higher inducible nitric oxide synthase (iNOS) and tumor necrosis factor (TNF) accumulation than did the same concentrations of pneumococci and clindamycin. Neither antibiotic alone or in combination with lipopolysaccharide acted directly on macrophages to modify the immune response. Endotoxin contamination did not confound the results, as preincubation with polymyxin B did not change iNOS or TNF protein levels. Thus, the antimicrobial mechanism of action affects macrophage inflammatory mediator production after stimulation with pneumococci.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023483     DOI: 10.1086/315861

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.

Authors:  Thomas P Lodise; Andrea Kwa; Leon Cosler; Reetu Gupta; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

2.  Mathematical model of a three-stage innate immune response to a pneumococcal lung infection.

Authors:  Amber M Smith; Jonathan A McCullers; Frederick R Adler
Journal:  J Theor Biol       Date:  2011-02-12       Impact factor: 2.691

3.  Thymidine starvation promotes c-di-AMP-dependent inflammation during pathogenic bacterial infection.

Authors:  Qing Tang; Mimi R Precit; Maureen K Thomason; Sophie F Blanc; Fariha Ahmed-Qadri; Adelle P McFarland; Daniel J Wolter; Lucas R Hoffman; Joshua J Woodward
Journal:  Cell Host Microbe       Date:  2022-04-18       Impact factor: 31.316

4.  Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages.

Authors:  Hridayesh Prakash; Anja Lüth; Natalia Grinkina; Daniela Holzer; Raj Wadgaonkar; Alexis Perez Gonzalez; Elsa Anes; Burkhard Kleuser
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

5.  Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.

Authors:  C A Gogos; A Skoutelis; A Lekkou; E Drosou; I Starakis; M N Marangos; H P Bassaris
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza.

Authors:  Asa Karlström; Kelli L Boyd; B Keith English; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

7.  Improving therapeutic strategies for secondary bacterial pneumonia following influenza.

Authors:  Jonathan A McCullers; B Keith English
Journal:  Future Microbiol       Date:  2008-08       Impact factor: 3.165

8.  Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.

Authors:  Arnab Majhi; Kiran Kundu; Rana Adhikary; Madhubanti Banerjee; Sayantika Mahanti; Anirban Basu; Biswadev Bishayi
Journal:  J Inflamm (Lond)       Date:  2014-02-24       Impact factor: 4.981

9.  Combination therapy with ampicillin and azithromycin improved outcomes in a mouse model of group B streptococcal sepsis.

Authors:  Kirtikumar Upadhyay; Basu Hiregoudar; Elizabeth Meals; Boyce Keith English; Ajay J Talati
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

10.  Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis.

Authors:  Hakim Echchannaoui; Stephen L Leib; Ulf Neumann; Regine M A Landmann
Journal:  BMC Infect Dis       Date:  2007-04-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.